Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CORCEPT THERAPEUTICS INC Director's Dealing 2012

Nov 26, 2012

30681_dirs_2012-11-26_be1bfbb5-e28f-411c-b8ce-695d4b25fbf3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2012-11-21

Reporting Person: BRADBURY DANIEL (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-11-21 Common stock P 80000 $1.3813 Acquired 80000 Indirect
2012-11-23 Common stock P 99000 $1.3988 Acquired 179000 Indirect

Footnotes

F1: Represents the average price per share.